Prevention of Diabetes and Complications

About Conference

                                 38th International Congress on Prevention of Diabetes and Complications

                                                                  April 27–28, 2027 | Paris, France

Welcome to the Conference

We are delighted to welcome you to the 38th International Congress on Prevention of Diabetes and Complications, taking place on April 27–28, 2027, in Paris, France. This international scientific congress will bring together endocrinologists, dialectologists, physicians, researchers, healthcare professionals, nutritionists, diabetes educators, public health experts, academicians, students, and representatives from the pharmaceutical and biotechnology industries. Diabetes continues to represent a major global health challenge, with prevention, early detection, effective management, and reduction of long-term complications remaining essential priorities. Type 2 diabetes can often be delayed or prevented through healthy nutrition, physical activity, weight management, risk assessment, and early intervention. The congress will provide a multidisciplinary platform to explore emerging research, innovative preventive strategies, advanced diagnostic technologies, therapeutic approaches, digital health solutions, and evidence-based methods for reducing diabetes-related complications.

Participants will have opportunities to exchange scientific knowledge, present their latest research, engage with international experts, establish professional collaborations, and explore new developments shaping the future of diabetes prevention and care.

Why Attend?

The 38th International Congress on Prevention of Diabetes and Complications offers an excellent opportunity to:

• Gain insights into the latest advances in diabetes prevention and management.
• Learn about emerging approaches for preventing diabetes-related complications.
• Hear from leading experts, researchers, clinicians, and healthcare professionals.
• Present your research through oral and poster presentations.
• Exchange knowledge and experiences with an international scientific community.
• Explore innovative technologies including continuous glucose monitoring, digital health, and artificial intelligence.
• Discuss current approaches to obesity, metabolic syndrome, cardiovascular risk, kidney disease, and diabetic complications.
• Develop new academic, clinical, and research collaborations.
• Participate in interactive scientific discussions, Q&A sessions, and networking opportunities.

Enhance professional knowledge and stay informed about emerging developments in diabetes and endocrinology.

Who Should Attend?

The congress welcomes:

• Endocrinologists and diabetologists

• Physicians and clinicians

• Diabetes researchers

• Academic scientists

• Nutritionists and dietitians

• Diabetes educators

• Nurses and allied healthcare professionals

• Public health professionals

• Cardiologists and nephrologists

• Ophthalmologists and podiatrists

• Pharmaceutical and biotechnology professionals

• Medical technology and digital health experts

• Postgraduate students

• PhD scholars

• Postdoctoral researchers

• Young investigators

• Healthcare policymakers

Join Us in Paris

Join us in Paris, France, on April 27–28, 2027, for two days of scientific exchange, innovation, collaboration, and discussion focused on one of the most important challenges in modern healthcare.

The 38th International Congress on Prevention of Diabetes and Complications aims to create a global forum where scientific discoveries, clinical expertise, preventive strategies, and technological innovations come together to advance diabetes care and help build a healthier future.

We look forward to welcoming you to Paris for an inspiring and scientifically enriching congress.

Call for Abstracts

Researchers, clinicians, academicians, healthcare professionals, students, and young investigators are invited to submit their original research and scientific work for presentation at the congress.

Abstracts may cover topics including:

• Diabetes prevention and early intervention
• Type 1 and Type 2 diabetes
• Prediabetes
• Obesity and metabolic syndrome
• Diabetes complications
• Cardiovascular and renal complications
• Diabetic retinopathy and neuropathy
• Nutrition and lifestyle interventions
• Diabetes education
• Pediatric and gestational diabetes
• Diabetes technology and CGM
• Artificial intelligence and digital health
• Genetics and precision medicine
• Emerging diabetes therapies
• Public health and population-based prevention
• Clinical and translational research

Abstracts can be submitted through the conference's online submission system. The official submission page requests author information, country, email, abstract category, track name, postal address, and an attached abstract file.

Presentation Opportunities

Accepted abstracts may be considered for:

• Oral Presentations
• Poster Presentations
• Young Researchers’ Presentations
• Scientific/Expert Sessions

Young researchers, postgraduate students, postdoctoral fellows, trainees, and junior faculty can also participate in the Young Researchers Forum, which is designed to provide opportunities to present research and gain professional exposure.

Registration

Participants are invited to register for the congress and join the international scientific community in Paris.

Registration Categories

• Speaker Registration
• Delegate Registration
• Student Registration
• Young Researcher Registration
• Poster Presenter Registration
• Exhibitor/Sponsor Registration
• Virtual Participation, where applicable

Registration provides participants with access to the scientific program and opportunities for knowledge exchange, networking, presentations, and professional engagement. The official conference website provides a dedicated registration option and directs participants to the registration page for applicable fees and categories.

Scientific Sessions / Tracks

1. Diabetes Prevention and Risk Reduction

This session will focus on strategies for preventing or delaying the onset of diabetes through early risk identification, lifestyle modification, population-based interventions, screening programs, and targeted preventive approaches. Discussions will highlight modifiable risk factors such as obesity, physical inactivity, unhealthy dietary patterns, hypertension, and metabolic abnormalities.

2. Prediabetes and Early Detection

This track will explore the identification and management of individuals at high risk of developing diabetes. Topics will include prediabetes, impaired glucose tolerance, impaired fasting glucose, biomarkers, risk-prediction models, screening strategies, and early interventions designed to prevent progression to type 2 diabetes.

3. Type 1 Diabetes: Prevention and Emerging Research

This session will address the latest developments in type 1 diabetes, including autoimmune mechanisms, genetic susceptibility, early detection, disease prediction, immunological interventions, beta-cell preservation, insulin therapy, and emerging preventive and therapeutic approaches.

4. Type 2 Diabetes: Prevention and Management

This track will examine the pathophysiology, risk factors, prevention, diagnosis, and management of type 2 diabetes. Presentations will cover insulin resistance, beta-cell dysfunction, glucose control, individualized treatment strategies, lifestyle interventions, and emerging therapeutic approaches.

5. Diabetic Clinical Care and Prevention

This session will emphasize comprehensive and patient-centered diabetes care. Topics will include glycemic control, HbA1c monitoring, blood pressure and lipid management, medication adherence, patient education, regular complication screening, and multidisciplinary strategies for reducing long-term health risks.

6. Obesity, Metabolic Syndrome and Diabetes

This track will explore the close relationship between obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. Discussions will include weight-management strategies, metabolic health, pharmacological approaches, nutrition, physical activity, obesity-related inflammation, and emerging interventions for diabetes prevention.

7. Diabetes and Cardiovascular Health

This session will focus on the prevention and management of cardiovascular disease in people with diabetes. Key topics will include hypertension, dyslipidemia, atherosclerosis, coronary artery disease, heart failure, stroke, cardiovascular risk assessment, and strategies for reducing cardiovascular morbidity and mortality.

8. Diabetes and Kidney Disease

This track will address diabetic kidney disease and chronic kidney disease, with emphasis on early detection, biomarkers, renal risk assessment, prevention, and kidney-protective treatment strategies. Cardiorenal health and emerging therapies for slowing disease progression will also be discussed.

9. Diabetic Retinopathy and Eye Health

This session will explore the prevention, screening, diagnosis, and treatment of diabetic eye complications. Topics will include retinal imaging, biomarkers, diabetic retinopathy, macular complications, AI-assisted screening, early intervention, and emerging therapies aimed at preventing diabetes-related vision loss.

10. Diabetic Neuropathy, Foot Care and Wound Management

This track will focus on peripheral and autonomic neuropathy, diabetic foot disease, ulcers, infection prevention, vascular complications, wound healing, and limb preservation. Discussions will highlight multidisciplinary approaches and innovative technologies for early identification and management.

11. Diabetes and Mental Health

This session will examine the psychological and behavioral impact of diabetes, including diabetes distress, depression, anxiety, treatment burden, lifestyle behavior, and patient motivation. Presentations will explore integrated approaches that combine metabolic and psychological care.

12. Pediatric and Adolescent Diabetes

This track will address diabetes in children and adolescents, including type 1 diabetes, childhood obesity, emerging type 2 diabetes, prevention, nutrition, physical activity, technology-assisted care, family education, and transition from pediatric to adult diabetes services.

13. Diabetes and Pregnancy

This session will focus on gestational diabetes and diabetes management during pregnancy. Topics will include screening and diagnosis, maternal and fetal outcomes, nutrition, glucose monitoring, pregnancy-related complications, postpartum care, and strategies for reducing future maternal and child metabolic risk.

14. Nutrition, Lifestyle and Exercise in Diabetes Prevention

This track will examine evidence-based dietary and lifestyle interventions for diabetes prevention and metabolic health. Topics will include healthy dietary patterns, calorie management, physical activity, exercise prescription, behavioral change, weight reduction, and sustainable lifestyle interventions.

15. Diabetes Education and Patient Empowerment

This session will explore innovative approaches to diabetes education and self-management. Discussions will cover health literacy, patient engagement, adherence, shared decision-making, digital education, behavioral support, and strategies that empower individuals to actively participate in their own care.

16. Continuous Glucose Monitoring and Diabetes Technology

This track will highlight advances in continuous glucose monitoring, wearable sensors, smart insulin delivery, connected devices, remote monitoring, mobile health applications, and digital platforms. The session will examine how technology can improve glucose control and support personalized diabetes management.

17. Artificial Intelligence and Digital Health in Diabetes

This session will explore the growing role of artificial intelligence, machine learning, predictive analytics, and digital health in diabetes care. Topics will include risk prediction, automated diagnosis, complication screening, personalized treatment, clinical decision support, remote care, and AI-assisted glucose management.

18. Genetics, Genomics and Precision Diabetes

This track will focus on genetic and molecular factors influencing diabetes susceptibility, progression, and treatment response. Discussions will include genomic medicine, biomarkers, epigenetics, pharmacogenomics, personalized prevention, and precision approaches to diabetes management.

19. Gut Microbiome and Metabolic Health

This session will examine the relationship between the gut microbiome, nutrition, obesity, insulin resistance, inflammation, and diabetes. Researchers will discuss microbiome-related biomarkers, dietary influences, metabolic pathways, and emerging microbiome-based approaches to diabetes prevention.

20. Innovative Diabetes Treatments and Future Therapies

This track will showcase emerging pharmacological and therapeutic strategies for diabetes. Topics will include novel drug targets, combination therapies, incretin-based approaches, insulin innovations, regenerative medicine, beta-cell replacement, and next-generation treatments.

21. Diabetes Complications: Prevention and Integrated Management

This session will provide an integrated perspective on preventing both microvascular and macrovascular complications. Discussions will cover cardiovascular disease, kidney disease, retinopathy, neuropathy, diabetic foot disease, screening, early intervention, and comprehensive risk-factor management. Diabetes complications can affect the heart, kidneys, eyes, nerves, and lower limbs, making regular screening and preventive care essential.

22. Public Health, Epidemiology and Global Diabetes Prevention

This track will examine the global burden of diabetes and population-level approaches to prevention and control. Topics will include epidemiology, screening programs, health policies, community interventions, health inequalities, prevention strategies, healthcare access, and the use of data to improve diabetes outcomes.

23. Translational and Clinical Diabetes Research

This session will connect laboratory discoveries with clinical applications. Presentations will cover biomarkers, clinical trials, real-world evidence, novel diagnostic approaches, therapeutic research, implementation science, and strategies for translating scientific discoveries into improved patient outcomes.

24. Emerging Trends and Future Directions in Diabetes

This forward-looking session will discuss the next generation of diabetes prevention, diagnosis, treatment, and complication management. Topics may include precision medicine, AI, digital therapeutics, novel biomarkers, regenerative approaches, advanced monitoring technologies, and innovative models of integrated diabetes care.

Market Analysis

The global diabetes market is experiencing significant growth, driven by the rising prevalence of diabetes, increasing obesity and metabolic disorders, greater awareness of early diagnosis, and growing demand for preventive and personalized healthcare. According to the International Diabetes Federation, approximately 589 million adults aged 20–79 were living with diabetes in 2024, representing 11.1% of the global adult population, and this number is projected to reach 853 million by 2050. The economic impact is equally substantial, with global healthcare expenditure related to diabetes exceeding USD 1 trillion in 2024. Alongside pharmaceuticals and therapeutics, the diabetes technology sector is expanding rapidly; the global diabetes care devices market was valued at approximately USD 35.09 billion in 2025 and is projected to reach USD 101.54 billion by 2034, reflecting strong demand for glucose monitoring, continuous glucose monitoring systems, insulin-delivery technologies, and connected healthcare solutions. These trends are creating substantial opportunities for pharmaceutical companies, biotechnology firms, medical-device manufacturers, digital-health providers, diagnostic companies, healthcare institutions, and research organizations. The 38th International Congress on Prevention of Diabetes and Complications, scheduled for April 27–28, 2027, in Paris, France, provides a valuable international platform for these stakeholders to exchange research, showcase innovations, develop collaborations, and explore emerging opportunities in diabetes prevention, early detection, complication management, digital health, and precision medicine.

Visa Process

We are committed to ensuring that your participation in Diabetes Meeting 2027 is as smooth and hassle-free as possible.

Our comprehensive visa support package includes:

• Official Invitation Letter: An official invitation from the conference organizers confirming your participation. (The official invitation letter will be provided upon completion of your conference registration and payment.)
• Abstract Acceptance Letter: Confirmation that your abstract has been accepted for presentation at the conference.
• Payment Receipt: Proof of your conference registration and payment.
• Visa Support Letter: A personalized letter outlining the purpose of your visit and the details of your stay in Paris. (The visa support letter will be provided upon completion of your conference registration and payment.)

These essential documents will be sent to you via email in PDF format to ensure quick and secure delivery.

We are dedicated to helping you navigate the visa application process efficiently, allowing you to focus on preparing for the conference. Should you have any questions or require additional assistance, please do not hesitate to contact us.

We look forward to welcoming you to Paris for a productive and enriching conference experience.

You may conveniently complete your payment through Payment Gateway/Stripe or via bank-to-bank transfer. For any inquiries or assistance regarding registration or invoices, please contact us at contact@europeanmeets.com.